PharmaSource: The External Manufacturing Community 13 Outsourcing Leader tickets left Apply for your pass Days Hours Minutes Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES Why Pharma Can’t Scale Like Tech Read More » SK pharmteco Announces $200M+ U.S. Investment in Small Molecules and Peptides 53Biologics Announces €2M+ Investment in New Lyophilization Capacity TAPI Appoints Serge Rogasik as Chief Executive Officer Emerald Clinical Trials Appoints Former Novotech COO Michael Stibilj as CEO to Lead Next Phase of Asia-Pacific CRO Growth Merck Opens €70M Expansion at St. Louis ADC Manufacturing Center NorthStar Medical Technologies Secures Up to $185M Growth Capital Facility Piramal Pharma Solutions Receives $1.75M Ontario Investment for Aurora Site Minaris Adds Viral Vectors Business Unit to Expand CGT Model Genezen Partners on AAV9 Gene Therapy for Ultra-Rare ARCA2 Disorder ESTEVE CDMO Expands Morton Grove Facility With $33M Total Investment Forge Biologics Partners With TECPR2 Research Foundation on AAV Gene Therapy Axplora Completes First R&D Batches of Exatecan for ADC Developers Serán Bioscience Announces Growth Investment to Expand Commercial Manufacturing BioToxTech Targets 200% Growth in U.S. and European Non-Clinical CRO Orders With Bundled Turnkey Package Model Quotient Sciences and Acesion Pharma Launch AI Formulation Collaboration More news + insights SK pharmteco Announces $200M+ U.S. Investment in Small Molecules and Peptides 53Biologics Announces €2M+ Investment in New Lyophilization Capacity TAPI Appoints Serge Rogasik as Chief Executive Officer PODCASTS How to Select and Sustain an Early-Stage CDMO Partnership What Changes When Pharma Outsources Outcomes, Not Just People? SPOTLIGHT Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] RESOURCES AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Resilience, Risk & Relationships – ExM Leaders Report Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] UPCOMING EVENTS CDMO Live Americas . October 20-21, Boston 2026 MASTERCLASS: De-Risking Technology Transfer in OSD AI + Digital Maturity in Contract Manufacturing 2026 External Manufacturing Leaders Dublin 2026
Emerald Clinical Trials Appoints Former Novotech COO Michael Stibilj as CEO to Lead Next Phase of Asia-Pacific CRO Growth
BioToxTech Targets 200% Growth in U.S. and European Non-Clinical CRO Orders With Bundled Turnkey Package Model